Rui Henrique

Citée par

	Toutes	Depuis 2020
Citations	17826	8750
indice h	73	45
indice i10	303	249

1900

950

475

1425

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202581 137 163 261 335 368 337 399 436 566 621 681 801 911 762 897 1115 1519 1784 1813 1706 1695 216

Accès public

Tout afficher

193 articles

42 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Carmen JeronimoPortuguese Oncology Institute of PortoAdresse e-mail validée de ipoporto.min-saude.pt
Manuel TeixeiraIPO-Porto and University of Porto, Porto, PortugalAdresse e-mail validée de ipoporto.min-saude.pt
David SidranskyProfessor Johns Hopkins UniversityAdresse e-mail validée de jhmi.edu
João Ramalho CarvalhoDivision of Oncogenomics - The Netherlands Cancer InstituteAdresse e-mail validée de nki.nl
Vera Miranda-GonçalvesResearch Center of Portuguese Oncology Institute of PortoAdresse e-mail validée de ipoporto.min-saude.pt
Vera ConstâncioMaster student in Oncology, University of PortoAdresse e-mail validée de icbas.up.pt
Luís OliveiraProfessor Adjunto do Departamento de Física, ISEP e Investigador no INESC TECAdresse e-mail validée de isep.ipp.pt
Mohammad Obaidul Hoque, DDS. Ph.D.Associate Professor of Otolaryngoloy and Head & Neck Surgery, Urology and OncologyAdresse e-mail validée de jhmi.edu
Valery TuchinProfessor of Saratov State UniversityAdresse e-mail validée de sgu.ru
Sara Monteiro-ReisPostdoctoral Fellow, Portuguese Oncology Institute – PortoAdresse e-mail validée de icbas.up.pt
Pedro Costa-PinheiroInstructor @ Neurosurgery CHOP/University of Pennsylvania, D3bAdresse e-mail validée de pennmedicine.upenn.edu
Andre Lopes CarvalhoDeputy Head, Cancer Prevention and Early Detection BrInternational Agency for Research on Cancer/WHOAdresse e-mail validée de iarc.who.int
Sofia SaltaPortuguese Oncology Institute of PortoAdresse e-mail validée de ipoporto.min-saude.pt
Diana Montezuma FelizardoIMP Diagnostics; Portuguese Oncology Institute of PortoAdresse e-mail validée de ipoporto.min-saude.pt
Filipa Quintela VieiraESTSP, IPO, ICBASAdresse e-mail validée de eu.ipp.pt
William WestraAdresse e-mail validée de jhmi.edu
João Diogo Barros SilvaPostdoctoral scientist, University of BirminghamAdresse e-mail validée de bham.ac.uk
Bruno M. CostaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of MinhoAdresse e-mail validée de med.uminho.pt
Rolf I. SkotheimDept. Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-RadiumhospitaletAdresse e-mail validée de uio.no
Leendert LooijengaProfessor Translational Patho-OncologyAdresse e-mail validée de prinsesmaximacentrum.nl

Suivre

Rui Henrique

Professor of Pathology, University of Porto

Adresse e-mail validée de icbas.up.pt - Page d'accueil

Pathology Uropathology Hematopathology Epigenetics Biomarkers


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma C Jerónimo, H Usadel, R Henrique, J Oliveira, C Lopes, WG Nelson, ... Journal of the National Cancer Institute 93 (22), 1747-1752, 2001	397	2001
A quantitative promoter methylation profile of prostate cancer C Jerónimo, R Henrique, MO Hoque, E Mambo, FR Ribeiro, G Varzim, ... Clinical Cancer Research 10 (24), 8472-8478, 2004	332	2004
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas, paired HGPIN lesions N Cerveira, FR Ribeiro, A Peixoto, V Costa, R Henrique, C Jerönimo, ... Neoplasia 8 (10), 826-832, 2006	307	2006
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects MO Hoque, O Topaloglu, S Begum, R Henrique, E Rosenbaum, ... Journal of Clinical Oncology 23 (27), 6569-6575, 2005	304	2005
Mitochondrial mutations in early stage prostate cancer and bodily fluids C Jeronimo, S Nomoto, OL Caballero, H Usadel, R Henrique, G Varzim, ... Oncogene 20 (37), 5195-5198, 2001	296	2001
Epigenetics in prostate cancer: biologic and clinical relevance C Jerónimo, PJ Bastian, A Bjartell, GM Carbone, JWF Catto, SJ Clark, ... European urology 60 (4), 753-766, 2011	267	2011
Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer C Jernimo, H Usadel, R Henrique, C Silva, J Oliveira, C Lopes, ... Urology 60 (6), 1131-1135, 2002	260	2002
BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment S Begum, E Rosenbaum, R Henrique, Y Cohen, D Sidransky, WH Westra Modern Pathology 17 (11), 1359-1363, 2004	241	2004
Diagnostic and prognostic epigenetic biomarkers in cancer P Costa-Pinheiro, D Montezuma, R Henrique, C Jerónimo Epigenomics 7 (6), 1003-1015, 2015	238	2015
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer N Pértega-Gomes, JR Vizcaíno, V Miranda-Gonçalves, C Pinheiro, J Silva, ... BMC cancer 11, 1-9, 2011	231	2011
A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions P Pimentel-Nunes, M Dinis-Ribeiro, JB Soares, R Marcos-Pinto, C Santos, ... Endoscopy 44 (03), 236-246, 2012	223	2012
Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro MJ Valente, AF Baltazar, R Henrique, L Estevinho, M Carvalho Food and Chemical Toxicology 49 (1), 86-92, 2011	219	2011
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma AL Carvalho, C Jeronimo, MM Kim, R Henrique, Z Zhang, MO Hoque, ... Clinical Cancer Research 14 (1), 97-107, 2008	218	2008
Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples VL Costa, R Henrique, SA Danielsen, S Duarte-Pereira, M Eknaes, ... Clinical Cancer Research 16 (23), 5842-5851, 2010	212	2010
Genome-wide promoter analysis uncovers portions of the cancer methylome MO Hoque, MS Kim, KL Ostrow, J Liu, GBA Wisman, HL Park, ML Poeta, ... Cancer research 68 (8), 2661-2670, 2008	210	2008
Molecular detection of prostate cancer: a role for GSTP1 hypermethylation R Henrique, C Jerónimo European urology 46 (5), 660-669, 2004	189	2004
DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types V Constâncio, SP Nunes, R Henrique, C Jerónimo Cells 9 (3), 624, 2020	185	2020
Profiling DNA methylation based on next-generation sequencing approaches: new insights and clinical applications D Barros-Silva, CJ Marques, R Henrique, C Jerónimo Genes 9 (9), 429, 2018	173	2018
Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic J Lobo, AJM Gillis, C Jerónimo, R Henrique, LHJ Looijenga International journal of molecular sciences 20 (2), 258, 2019	152	2019
High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients R Henrique, FR Ribeiro, D Fonseca, MO Hoque, AL Carvalho, VL Costa, ... Clinical cancer research 13 (20), 6122-6129, 2007	147	2007

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs